Eze Vidra, who helped GV set up its aborted European branch, has taken the chief innovation officer role at clinical trial connection platform TrialReach.
Eze Vidra, formerly a general partner at corporate venturing unit Google Ventures’ European office, has been appointed chief innovation officer of clinical trials sourcing platform TrialReach, the Financial Times has reported.
Vidra was a co-founder of Google Ventures Europe, the London-based offshoot of the unit, which is now known as GV, in July 2014.
The European office was given $125m in capital but was absorbed back into GV at the end of 2015 after making relatively few investments. Vidra, who…
